Piramal Healthcare Ltd announced a net profit of Rs 201.85 crore for the fourth quarter ended March 31, 2011. The company had posted a net profit of Rs 154.32 crore in the corresponding quarter last month.
However, the figures are not comparable because of the domestic sale of the domestic formulation business and diagnostics services.
The company's net sales for the quarter stood at Rs 559 crore against Rs 941 crore for the corresponding quarter last year.
Piramal Healthcare's consolidated net profit for the year ended March 31, 2011 stood at Rs 12,883.36 crore. It was Rs 481.90 crore in the previous fiscal. The net sales for the full fiscal stood at Rs 2,555 crore as against Rs 3,671 crore in the previous fiscal.
Dividend
The board has recommended dividend of Rs 6 per equity share of face value of Rs 2/- (at the rate of 300 per cent) for the financial year ended March 31, 2011. In addition to this, it has also recommended a one-time special dividend of Rs 6 per equity share of face value Rs 2 (at the rate of 300 per cent) as a further reward to shareholders consequent to the sale of domestic formulations business which took place during the financial year.
Thus, the total dividends recommended by the board, therefore, aggregates to Rs 12 per equity share of face value of Rs 2 (at the rate of 600%).
Shares of Piramal Healthcare on Friday closed at Rs 458.80 on BSE, up 0.04 per cent from the previous close.